“Generation of recombinant hyperimmune globulins from diverse B-cell repertoires” publication in Nature Biotechnology

Congratulations to Alira Health’s Steven Chamow, Senior Vice President, CMC and founder of Chamow & Associates, and to Bryan Monroe and Chuck Olson, Senior Consultants, on their contributions to “Generation of recombinant hyperimmune globulins from…

Comments Off on “Generation of recombinant hyperimmune globulins from diverse B-cell repertoires” publication in Nature Biotechnology

A Primer on Potency Assays for Release of Biologics

In this piece, Nicolas Gaspar, Ph.D., Senior Consultant, Bioassay Development and Quality Control, offers insights for working with a CDMO by digging into the importance of potency as a quality…

Comments Off on A Primer on Potency Assays for Release of Biologics

2020 BPI Readers’ Choice Award for “Capture of CH1-Containing Bispecific Antibodies: Evaluating an Alternative to Protein A”

Chamow & Associates is pleased to announce that BioProcess International has awarded our article, “Capture of CH1-Containing Bispecific Antibodies: Evaluating an Alternative to Protein A,” by Steven M. Chamow, Angela Linderholm, Katherine…

Comments Off on 2020 BPI Readers’ Choice Award for “Capture of CH1-Containing Bispecific Antibodies: Evaluating an Alternative to Protein A”